4.3 Article

Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 β production in a cancer-induced pain model in mice

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Interleukin 1 beta gene promoter SNPs are associated with risk of pancreatic cancer

Rainer Hamacher et al.

CYTOKINE (2009)

Article Oncology

Management of cancer pain: Basic principles and neuropathic cancer pain

B. Laird et al.

EUROPEAN JOURNAL OF CANCER (2008)

Article Endocrinology & Metabolism

Pre-clinical evaluation of a new orally-active CCK-2R antagonist, Z-360, in gastrointestinal cancer models

A. M. Grabowska et al.

REGULATORY PEPTIDES (2008)

Article Pharmacology & Pharmacy

Preclinical assessment of candidate analgesic drugs: Recent advances and future challenges

S. S. Negus et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)

Review Anesthesiology

The role of N-methyl-D-aspartate (NMDA) receptors in pain:: A review

AB Petrenko et al.

ANESTHESIA AND ANALGESIA (2003)

Article Pharmacology & Pharmacy

NMDA receptors as targets for drug action in neuropathic pain

CG Parsons

EUROPEAN JOURNAL OF PHARMACOLOGY (2001)

Article Biochemistry & Molecular Biology

Characterization of Fyn-mediated tyrosine phosphorylation sites on GluRε2 (NR2B) subunit of the N-methyl-D-aspartate receptor

T Nakazawa et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)